CD8A and neoplasm: Some TILs behave as effector cells, such as CD8+ and natural killer lymphocytes [17], inducing a cytotoxic cascade resulting in tumour cell death, while other TILs show a regulatory role inhibiting the anti-tumour activity of effector T cells [18].